<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00356044</url>
  </required_header>
  <id_info>
    <org_study_id>CEICG 2004/063</org_study_id>
    <nct_id>NCT00356044</nct_id>
  </id_info>
  <brief_title>Arterial Access for Coronary Intervention in Myocardial Infarction</brief_title>
  <official_title>Femoral Versus Radial Access for Coronary Intervention in the Acute Phase of ST-Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Juan Canalejo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Juan Canalejo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the radial and femoral access for percutaneous
      interventions in the acute phase of the ST elevation acute myocardial infarction in terms of
      efficacy and security.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Some groups have previously used the radial artery as the access route in the procedures of
      percutaneous coronary revascularization, with good results. The advantages of the radial
      compared with femoral access are related to a lower incidence of vascular complications. The
      radial access has also inconveniences such as a less predictable anatomy which can make the
      procedure difficult and prolong the time required.The patients with ST elevation myocardial
      infarction have an increased risk of vascular complications after interventional procedures
      because previous antithrombotic or thrombolytic therapy.On the other hand, the time and
      success of the procedure are significant prognostic issues.In this sitting, the radial
      approach might reduce vascular complications and increase other cardiovascular events when
      comparing with the classical femoral access. For this reason, the purpose of the study is to
      compare both arterial access in terms of efficacy and security and to quantify the
      consequences of the advantages and drawbacks of both.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2004</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality at 30 days</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>New ST elevation acute myocardial infarction at 30 days</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronary revascularization as a result of recurrent ischemia at 30 days</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Major vascular complications at 30 days.</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Embolic stroke at 30 days</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coronary revascularization at 30 days</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality at 30 days</measure>
    <time_frame>within the first 30 days (plus or minus 5 days) after the index myocardial infarction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural time</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of costs</measure>
  </secondary_outcome>
  <enrollment type="Actual">439</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Angioplasty, Transluminal, Percutaneous Coronary</condition>
  <condition>Myocardial Reperfusion</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angioplasty</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ST elevation acute myocardial infarction referred for
             primary,facilitated or of rescue coronary angioplasty in the first 12 hours since the
             start of the symptoms.

        Exclusion Criteria:

          -  Patients in cardiogenic shock were excluded following operator criteria.

          -  Previous coronary surgery with mammary artery graft

          -  Coronary artery intervention in the previous month

          -  Absolute or relative contraindication for access via the radial artery route:Radial
             pulse absent or weak, abnormal Allen test,anatomy known to impede the use of the
             radial route or hemodialysis or advanced chronic renal insufficiency (creatinine &gt;3
             mg/dl).

          -  Patients with absolute or relative contraindication for the use of the femoral route.

          -  Absence of informed consent from the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose M Vazquez-Rodriguez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Juan Canalejo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose A Baz, Alonso</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital do meixoeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrés Iñiguez-Romo, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital do Meixoeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolás Vázquez-González, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Juan Canalejo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ramón Calviño-Santos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Juan Canalejo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Amaro-Cendón, MD</last_name>
    <role>Study Director</role>
    <affiliation>Complejo Hospitalario Universitario de Santiago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ramiro Trillo, Nouche</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario Universitario de Santiago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Complexo Hospitalario Universitario de Santiago</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital do Meixoeiro</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <zip>36200</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Canalejo</name>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Saito S, Tanaka S, Hiroe Y, Miyashita Y, Takahashi S, Tanaka K, Satake S. Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial. Catheter Cardiovasc Interv. 2003 May;59(1):26-33.</citation>
    <PMID>12720237</PMID>
  </reference>
  <reference>
    <citation>Exaire JE, Dauerman HL, Topol EJ, Blankenship JC, Wolski K, Raymond RE, Cohen EA, Moliterno DJ; TARGET Investigators. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. Am Heart J. 2004 Jan;147(1):31-4.</citation>
    <PMID>14691415</PMID>
  </reference>
  <results_reference>
    <citation>Vazquez Rodriguez JM, Calvino Santos R, Baz Alonso JA, Trillo Nouche R, Salgado Fernandez J, Sanmartin Fernandez M, et al. Radial vs. Femoral access in emergent coronary interventions for acute myocerdial infarction with ST segment elevation (abstract). Innovation in Intervention: i2 Summit 2007 Abstract Sessions. 10.1016/j.jacc.2007.01.048. J Am Coll Cardiol 2007;49(9_Suppl_B):12B.</citation>
  </results_reference>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2006</study_first_submitted>
  <study_first_submitted_qc>July 24, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2006</study_first_posted>
  <last_update_submitted>July 10, 2007</last_update_submitted>
  <last_update_submitted_qc>July 10, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2007</last_update_posted>
  <keyword>Transradial access</keyword>
  <keyword>Femoral access</keyword>
  <keyword>Femoral vs radial access</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

